The California STEM Reporter: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The California STEM Reporter.

Press releases published on September 10, 2026

Inuvo to Present at the H.C. Wainwright 28th Annual Global Investment Conference on September 14th-16th
Oncolytics Biotech® Announces Positive Preclinical Results Combining Pelareorep with a Pan-RAS Inhibitor in Colorectal Cancer
Aptean lanserer nestegenerasjons, skybasert og KI-drevet administrasjonssystem for utstyrsforhandlere
Aptean lanserar nästa generations molnbaserade och AI-drivna hanteringssystem för utrustningsåterförsäljare
SPARC AI Launches Overwatch Patrol at MSPO in Poland
Generative Engine Optimisation: Azoma on Which GEO Tools Help Brands Losing Search Traffic to AI Answers
NKGen Biotech to Present on Potential of Troculeucel in Neurodegenerative Diseases at Biologics Manufacturing Korea 2026
Verrica Pharmaceuticals to Present YCANTH® and VP-315 Data at Two Upcoming Dermatology Conferences
Candel Therapeutics Appoints Martine Zimmermann, PharmD, to its Board of Directors
Bull selected to modernise Spain’s national weather forecasting infrastructure
Bull elegida para modernizar la infraestructura nacional de predicción meteorológica de España
   Bull choisi pour moderniser l’infrastructure nationale de prévision météorologique en Espagne
Pasqal and LG CNS partner to power Next-generation AI Data centers with quantum computing
Starton Therapeutics to Present at MedInvest Biotech & Pharma Conference
Biora Therapeutics to Initiate First Human Trial of BioJet™ Oral Biologic Delivery Capsule
Adagene Announces that Third Arc Bio Has Selected First Lead Candidate under Amended Strategic Collaboration for Development of Masked CD3 T Cell Engagers Utilizing SAFEbody® Technology
BGI Group Showcases New Technologies for Advancing Personalized Health at 2026 Global New Product Launch Event
ORYZON to Participate in Upcoming Events in September and October
Electra Therapeutics Announces Initiation of a Phase 1 Trial of ELA822, a Novel SIRPγ-Specific Antibody Designed to Treat T Cell-Mediated Immune and Inflammatory Diseases
Rhythm Pharmaceuticals Announces New Data Presentations at the European Society for Paediatric Endocrinology Meeting

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

The California STEM Reporter

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.